Avoiding Delays on the Pathway to Clinic
Summary: Time is of the essence in the biopharmaceutical industry. How can developers ensure they get to the clinic as efficiently and smoothly as possible? In this Q&A article, a Catalent Biologics expert discusses issues that could delay the path to clinic for a biologic and how to avoid them.